术前低密度脂蛋白水平对下肢血运重建结局的影响
该回顾性研究纳入2039例下肢血运重建患者,分析术前低密度脂蛋白(LDL)检测趋势及其对结局的影响。结果显示33.1%患者术前未检测LDL,达到LDL<70 mg/dL者仅约36%,且术前LDL<70 mg/dL与主要不良心血管事件、肢体事件或死亡率无显著关联。
要点
- 33.1%的下肢血运重建患者术前未检测LDL。
- 研究期间LDL检测率(39.3%→66.2%)和他汀使用率(74.4%→81%)上升。
- 术前LDL<70 mg/dL与心血管事件、肢体事件或死亡无显著关联。
核心结论
- 下肢血运重建术前血脂检测和他汀使用增加,但多数患者基线LDL仍高于指南推荐目标。
- 术前LDL<70 mg/dL与主要不良心血管事件、肢体事件或死亡率无显著关联。
研究设计与样本
- 回顾性病历审查,纳入2013至2020年接受开放、腔内或杂交下肢血运重建的患者2039例,随访至2024年。
- 根据术前基线LDL是否<70 mg/dL分为两组,比较特征和结局。
主要发现
- 2039例患者中33.1%术前未检测LDL。
- 研究期间术前LDL检测比例从39.3%增至66.2%,他汀使用从74.4%增至81%,基线LDL<70 mg/dL者比例持续约36%。
- 低LDL组更可能为老年白人男性,合并症负担更高,因慢性肢体威胁性缺血接受治疗。
- 生存和Cox回归分析未显示基线LDL<70 mg/dL与主要不良心血管事件、肢体事件或死亡率显著相关。
关键数值与推荐
- 近期指南推荐外周动脉疾病(PAD)患者LDL<70 mg/dL。
- 研究期间LDL检测比例39.3-66.2%,他汀使用74.4-81%,基线LDL<70 mg/dL者约36%。
临床怎么用
- 下肢血运重建术前应常规检测LDL并评估他汀使用,以识别与指南目标的差距。
- 术前LDL<70 mg/dL未显示与结局改善相关,但仍需按指南管理血脂。
局限性
- 回顾性单中心设计可能限制普遍性。
- 基线LDL<70 mg/dL与结局无显著关联,不能排除未测量混杂因素影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent guidelines recommend achieving low-density lipoprotein (LDL) < 70 mg/dL in patients with peripheral arterial disease (PAD). This study assesses the trends in LDL testing and its impact on lower extremity revascularization (LER) outcomes in a tertiary center. METHODS: A retrospective chart review of patients who underwent open, endovascular, or hybrid LER between 2013 and2020 was performed, with follow-up extending into 2024. Patients were divided into 2 groups based on baseline LDL < 70 mg/dL or higher prior to LER. Characteristics and outcomes of the 2 groups were compared. RESULTS: Of 2,039 patients that underwent LER, 33.1% did not have LDL testing prior to intervention. The proportion of patients with preoperative LDL testing significantly increased over the study period (39.3-66.2%) concomitantly with increased statin use (74.4-81%), while the proportion of patients with baseline LDL < 70 mg/dL remained low (∼36%). Patients with low LDL were more likely to be older White males with significantly higher burden of comorbidities treated for chronic limb-threatening ischemia. Survival and Cox regression analysis did not demonstrate significant association of baseline LDL < 70 mg/dL with major adverse cardiovascular events, limb events, or mortality. CONCLUSION: Lipid testing and statin use prior to LER have increased, but most patients had baseline LDL higher than the suggested target by most recent guidelines. A preoperative LDL < 70 mg/dL did not demonstrate an association with outcomes. This study highlights a significant gap in the care of patients with PAD undergoing LER and an opportunity for improvement by application of contemporary guidelines.
引用
- Carter WJ, Alappan UD, Chetty AK, et al. Impact of Preoperative LDL Level on Lower Extremity Revascularization Outcomes. Ann Vasc Surg. 2025. PMID: 40651525. doi:10.1016/j.avsg.2025.07.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。